Insomnia Signs and Symptoms

Signs and Symptoms

Introduction

The subjective perception of difficulty in sleep initiation, duration, consolidation, or quality of sleep, occurring despite adequate opportunities for sleep, and resulting in daytime dysfunction
The most prevalent sleep disorder in the general population, therefore, it is an important public health problem that needs accurate diagnosis and effective treatment
Approximately 10% of adults have insomnia
- 30-50% of the population is affected by occasional, short-term insomnia
- The prevalence of chronic insomnia disorder is estimated to be at least 5-10% in industrialized nations
- More common in females and older adults

Risk Factors

Increasing age
- Elderly individuals must be assessed for insomnia as they report more forms of sleeping difficulty including lower rates of sleep efficiency, longer sleep onset times, increased number of nighttime awakenings, more time in bed, earlier wake up times and more daytime naps
Female gender
Medical and psychiatric disease (eg depression, mood disorders)
Socioeconomic factors (eg marital strain, financial strain, unemployment)

Long COVID: What we have learned so far

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

NCDs in Focus Act Now! Summit 2022

16 Mar 2023

Viatris, a global healthcare company, collaborated with the Thai Hypertension Society and the Thai NCD Collaboration Group to organize the NCDs in Focus Act Now! Summit 2022 in Bangkok on October 29^th and 30^th. This summit brought together nearly 300 multidisciplinary experts from Southeast Asia and India to address the unmet needs in managing two critical noncommunicable diseases (NCDs): cardiovascular diseases (CVDs) and mental health disorders (MHDs) in the region.

The summit had several key objectives. Firstly, it highlighted the effectiveness of clinical data in addressing gaps and unmet needs in clinical practice. Secondly, it emphasized the importance of sharing expertise and best practices through a platform that can optimize patient care. Additionally, it discussed the challenges of cardiovascular disease and mental health disorder care in a post COVID-19 world, and the need to re-examine them.

The summit also offered valuable insights into policy and practice changes, as well as innovative digital solutions that can lead to better outcomes. Lastly, it emphasized the significance of gaining a deeper understanding of the gaps in the patient journey to enhance patient care further.

Overall, the NCDs in Focus Act Now! Summit 2022 was a highly informative and productive event, with experts collaborating to improve the management of CVDs and MHDs in Southeast Asia and India.